Schistosoma species energy metabolism enzymes

Schistosoma species energy metabolism enzymes constitute a vital group of proteins required for the survival, growth, and reproduction of blood flukes within their mammalian hosts [1.1.1, 1.3.1]. These parasites are highly dependent on carbohydrate metabolism, particularly anaerobic glycolysis, to generate the energy necessary for maintaining their tegumental integrity and high rates of egg production [1.3.1, 1.4.1]. Key enzymes in this category include glycolytic proteins such as hexokinase, phosphofructokinase, and enolase, as well as mitochondrial components like succinate dehydrogenase [1.1.4, 1.2.1, 1.3.1]. Because these enzymes are central to the parasite's physiology, they have been extensively studied as potential therapeutic targets [1.2.1, 1.2.2]. Several existing drugs, including mefloquine and artemether, exert their antischistosomal effects by inhibiting specific enzymes within this metabolic network [1.1.4, 1.3.1]. However, the high degree of structural conservation between schistosome enzymes and their human orthologs presents a significant challenge for drug design, requiring the identification of parasite-specific features to ensure safety and efficacy [1.3.1]. Targeting this metabolic machinery remains a promising strategy for developing new treatments to overcome the limitations of current monotherapy [1.2.1, 1.3.1].

Other names

Schistosome metabolic enzymesSchistosome glycolytic enzymesSchistosoma energy metabolism targetsSchistosome energy metabolism enzymes

Inhibition of parasite energy production through the disruption of glycolytic and mitochondrial enzymatic pathways.